Publikacje 2023

I. Mojzych, A. Zawadzka, K. Kaczynska, P. Wojciechowski, D. Zając, M. Chotkowski, K. Wiktorska, J.K. Maurin, M. Mazur
“Tetrahydroacridine derivative and its conjugate with gold nanoparticles: Promising agents for the treatment of Alzheimer’s disease”
Phys. Chem. Chem. Phys. 25, 16769 (2023)

Publikacje 2022

A.S. Fernández, A.G. Gago, F.A. Naveda, J.G. Calleja, A. Zawadzka, Z. Czarnocki, J.C. Mayo Barrallo, R.M. Sainz Menéndez, P. Rodríguez-González, J.I.G. Alonso
“Evaluation of different internal standardization approaches for the quantification of melatonin in cell culture samples by multiple heart-cutting two dimensional liquid chromatography tandem mass spectrometry”
Journal of Chromatography A 1663, 462752 (2022)

Publikacje 2021

Molęda, A. Zawadzka, Z. Czarnocki, L. Monjas, A.K.H. Hirsch, A. Budzianowski, J.K. Maurin
“Clicking“ fragment leads to novel dual-binding cholinesterase inhibitors
Bioorganic and Medicinal Chemistry 42, 116269 (2021)

Strus P., Borensztejn K., Szczepankiewicz A.A., Lisiecki K., Czarnocki Z., Nieznanska H., Wojcik C., Bialy Ł.P., Mlynarczuk-Bialy I.,
“Novel podophyllotoxin and benzothiazole derivative induces transitional morphological and functional changes in HaCaT cells”
Toxicology in Vitro, 73, 105144 (2021)

Szulczyk D., Bielenica A., Roszkowski P., Dobrowolski M.A., Olejarz W., Kmiecik S., Podsiad M., Struga M.
„Synthetic transition from thiourea-based compounds to tetrazole derivatives: structure and biological evaluation of synthesized new N-(furan-2-ylmethyl)-1H-tetrazol-5-amine derivatives”
Molecules, 26, 323 (2021)

Publikacje 2020

Szulczyk D., Bielenica A., Roszkowski P., Dobrowolski M., Olejarz W., Napiórkowska M., Struga M.,
„Cytotoxicity evaluation of novel bis(2-aminoethyl)amine derivatives”
Molecules, 25, 2816 (2020)

Szulczyk D., Bielenica A., Głogowska A., Augustynowicz-Kope E., Dobrowolski M., Roszkowski P., Stępień K., Chrzanowska A., Struga M.,
„Development of (4-methoxyphenyl)-1H-tetrazol-5-amine regioisomers as a new class of selective antitubercular agents”
Eur J Med Chem, 186, 111882 (2020)

Chrzanowska A., Roszkowski P., Bielenica A., Olejarz W., Stępień K., Struga M.,
„Anticancer and antimicrobial effects of novel ciprofloxacin fatty acids conjugates”
Eur J Med Chem, 185, 111810 (2020)

Krawczyk K.K., Lisiecki K., Czarnocki Z.,
“Unique cyclolignan’s architecture obtained via acid catalyzed cyclization/intramolecular Friedel-Crafts tandem reaction”
Arkivoc, part vii, 46-55 (2020)

Publikacje 2019

Stanislawska, IJ; Granica, S; Piwowarski, JP; Szawkało, J; Wiazecki, K; Czarnocki, Z; Kiss, AK,
„The Activity of Urolithin A and M4 Valerolactone, Colonic Microbiota Metabolites of Polyphenols, in a Prostate Cancer In Vitro Model”
PLANTA MEDICA 85, 2, 118-125 (2019)

W. Olejarz, M. Wrzosek, M. Jóźwiak, E. Grosicka-Maciąg, P. Roszkowski, A. Filipek, A. Cychol, G. Nowicka, M. Struga,
„Synthesis and anticancer effects of α-lipoic ester of alloxanthoxyletin” Medicinal Chemistry Research 28, 788-796 (2019)

P.F.J. Lipiński, P. Kosson, J. Matalińska, P. Roszkowski, Z. Czarnocki, M. Jarończyk, A. Misicka, J. Cz. Dobrowolski, J. Sadlej,
„Fentanyl Family at the Mu-Opioid Receptor: Uniform Assessment of Binding and Computational Analysis” Molecules 24, 740 (2019)

Pomarański P., Czarnocki Z.
„L-Prolinal Dithioacetal: A Highly Effective Organocatalyst for the Direct Nitro-Michael Addition to Selected Cyclic and Aromatic Ketones” Synthesis, 51, 3356-3368 (2019)

Jóźwiak, M. Struga, P. Roszkowski, A. Filipek, G. Nowicka, W. Olejarz,
„Anticancer effects of alloxanthoxyletin and fatty acids esters – In vitro study on cancer HTB-140 and A549 cells” Biomedicine&Pharmacoteraphy 110, 618-630 (2019)

Pomarański P., Czarnocki Z.
„Arylpyridines: A Review from Selective Synthesis to Atropisomerism” Synthesis, 51, 587-611 (2019)

Pomarański P., Roszkowski P., Maurin J.K., Czarnocki Z.,
“Regio- and atropselective synthesis of selected ortho-phenyl substituted arylpyridine derivatives” Journal of Molecular Structure, 1177, 564-570 (2019)